GlassScriptPhysician profile
Dana R Lambert
NPI 1124324751
$477.73
in general payments reported to CMS, 2019-2025
12 companies · $27.90 in 2025
The $27.90 reported for 2025 was less than what a typical Nurse Anesthetist, Certified Registered provider received nationally (typical 2025 total: $45.72).
See the full distribution for Nurse Anesthetist, Certified Registered
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $71.56 · 2022: $52.87 · 2023: $263 · 2024: $62.11 · 2025: $27.90.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $353.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $353.30 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ethicon INC. | $111.60 | 2023-2024 | Monarch Platform |
| Avanos Medical | $71.56 | 2021 | |
| Astrazeneca Pharmaceuticals LP | $60.92 | 2023 | Tagrisso |
| Novartis Pharmaceuticals Corporation | $60.41 | 2023 | |
| Janssen Biotech, INC. | $31.00 | 2022 | |
| Pfizer INC. | $27.90 | 2025 | |
| Dendreon Pharmaceuticals LLC | $24.31 | 2024 | Provenge |
| Takeda Pharmaceuticals U.S.A., INC. | $22.93 | 2023 | Alunbrig |
| Eisai INC. | $21.87 | 2022 | |
| Aveo Pharmaceuticals, INC. | $15.82 | 2023 | Fotivda |
| Puma Biotechnology, INC. | $15.31 | 2023 | |
| Cumberland Pharmaceuticals, INC. | $14.10 | 2024 | Sancuso |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Dana Lambert listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.